165 related articles for article (PubMed ID: 37148759)
1. Coordination of chemical analyses under the European Human Biomonitoring Initiative (HBM4EU): Concepts, procedures and lessons learnt.
Vorkamp K; Esteban López M; Gilles L; Göen T; Govarts E; Hajeb P; Katsonouri A; Knudsen LE; Kolossa-Gehring M; Lindh C; Nübler S; Pedraza-Díaz S; Santonen T; Castaño A
Int J Hyg Environ Health; 2023 Jun; 251():114183. PubMed ID: 37148759
[TBL] [Abstract][Full Text] [Related]
2. Application of human biomonitoring data to support policy development, raise awareness and environmental public health protection among countries within the HBM4EU project.
Ubong D; Stewart L; Sepai O; Knudsen LE; Berman T; Reynders H; Van Campenhout K; Katsonouri A; Van Nieuwenhuyse A; Ingelido AM; Castaño A; Pedraza-Díaz S; Eiríksdóttir ÁV; Thomsen C; Hartmann C; Gjorgjev D; De Felip E; Tolonen H; Santonen T; Klanova J; Norström K; Kononenko L; Silva MJ; Uhl M; Kolossa-Gehring M; Apel P; Jõemaa M; Jajcaj M; Estokova M; Luijten M; Lebret E; von Goetz N; Holcer NJ; Probst-Hensch N; Cavaleiro R; Barouki R; Tarroja E; Balčienė RM; Strumylaite L; Latvala S; Namorado S; Szigeti T; Ingi Halldorsson T; Olafsdottir K; Wasowicz W;
Int J Hyg Environ Health; 2023 Jun; 251():114170. PubMed ID: 37207539
[TBL] [Abstract][Full Text] [Related]
3. Phthalates and substitute plasticizers: Main achievements from the European human biomonitoring initiative HBM4EU.
Gerofke A; Lange R; Vogel N; Schmidt P; Weber T; David M; Frederiksen H; Baken K; Govarts E; Gilles L; Martin LR; Martinsone Ž; Santonen T; Schoeters G; Scheringer M; Domínguez-Romero E; López ME; Calvo AC; Koch HM; Apel P; Kolossa-Gehring M
Int J Hyg Environ Health; 2024 Jun; 259():114378. PubMed ID: 38631089
[TBL] [Abstract][Full Text] [Related]
4. The European human biomonitoring platform - Design and implementation of a laboratory quality assurance/quality control (QA/QC) programme for selected priority chemicals.
Esteban López M; Göen T; Mol H; Nübler S; Haji-Abbas-Zarrabi K; Koch HM; Kasper-Sonnenberg M; Dvorakova D; Hajslova J; Antignac JP; Vaccher V; Elbers I; Thomsen C; Vorkamp K; Pedraza-Díaz S; Kolossa-Gehring M; Castaño A
Int J Hyg Environ Health; 2021 May; 234():113740. PubMed ID: 33774419
[TBL] [Abstract][Full Text] [Related]
5. Interlaboratory Comparison Investigations (ICIs) for human biomonitoring of chromium as part of the quality assurance programme under HBM4EU.
Nübler S; Schäfer M; Haji-Abbas-Zarrabi K; Marković S; Marković K; Esteban López M; Castaño A; Mol H; Koch HM; Antignac JP; Hajslova J; Thomsen C; Vorkamp K; Göen T
J Trace Elem Med Biol; 2022 Mar; 70():126912. PubMed ID: 34954563
[TBL] [Abstract][Full Text] [Related]
6. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A.
Ougier E; Zeman F; Antignac JP; Rousselle C; Lange R; Kolossa-Gehring M; Apel P
Environ Int; 2021 Sep; 154():106563. PubMed ID: 33894553
[TBL] [Abstract][Full Text] [Related]
7. HBM4EU feasibility studies: Lessons learned in combining health and human biomonitoring studies.
Elonheimo HM; Uusitalo K; Moore S; Andersson AM; Baber R; Wirkner K; David M; Kolossa-Gehring M; Stewart L; Sepai O; Lermen D; Bartel-Steinbach M; Rantakokko P; Koponen J; Tolonen H
Int J Hyg Environ Health; 2023 Mar; 248():114100. PubMed ID: 36508963
[TBL] [Abstract][Full Text] [Related]
8. Interlaboratory comparison investigations (ICI) and external quality assurance schemes (EQUAS) for cadmium in urine and blood: Results from the HBM4EU project.
Nübler S; López ME; Castaño A; Mol H; Schäfer M; Haji-Abbas-Zarrabi K; Bury D; Koch HM; Vaccher V; Antignac JP; Dvorakova D; Hajslova J; Thomsen C; Vorkamp K; Göen T
Int J Hyg Environ Health; 2021 May; 234():113711. PubMed ID: 33714064
[TBL] [Abstract][Full Text] [Related]
9. External Quality Assurance Schemes (EQUASs) and Inter-laboratory Comparison Investigations (ICIs) for human biomonitoring of polycyclic aromatic hydrocarbon (PAH) biomarkers in urine as part of the quality assurance programme under HBM4EU.
Nübler S; Esteban López M; Castaño A; Mol HGJ; Müller J; Schäfer M; Haji-Abbas-Zarrabi K; Hajslova J; Pulkrabova J; Dvorakova D; Urbancova K; Koch HM; Antignac JP; Sakhi AK; Vorkamp K; Burkhardt T; Scherer M; Göen T
Int J Hyg Environ Health; 2023 May; 250():114169. PubMed ID: 37099846
[TBL] [Abstract][Full Text] [Related]
10. Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants.
Gilles L; Govarts E; Rodriguez Martin L; Andersson AM; Appenzeller BMR; Barbone F; Castaño A; Coertjens D; Den Hond E; Dzhedzheia V; Eržen I; López ME; Fábelová L; Fillol C; Franken C; Frederiksen H; Gabriel C; Haug LS; Horvat M; Halldórsson TI; Janasik B; Holcer NJ; Kakucs R; Karakitsios S; Katsonouri A; Klánová J; Kold-Jensen T; Kolossa-Gehring M; Konstantinou C; Koponen J; Lignell S; Lindroos AK; Makris KC; Mazej D; Morrens B; Murínová ĽP; Namorado S; Pedraza-Diaz S; Peisker J; Probst-Hensch N; Rambaud L; Rosolen V; Rucic E; Rüther M; Sarigiannis D; Tratnik JS; Standaert A; Stewart L; Szigeti T; Thomsen C; Tolonen H; Eiríksdóttir Á; Van Nieuwenhuyse A; Verheyen VJ; Vlaanderen J; Vogel N; Wasowicz W; Weber T; Zock JP; Sepai O; Schoeters G
Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682369
[TBL] [Abstract][Full Text] [Related]
11. Mixture risk assessment and human biomonitoring: Lessons learnt from HBM4EU.
Luijten M; Vlaanderen J; Kortenkamp A; Antignac JP; Barouki R; Bil W; van den Brand A; den Braver-Sewradj S; van Klaveren J; Mengelers M; Ottenbros I; Rantakokko P; Kolossa-Gehring M; Lebret E
Int J Hyg Environ Health; 2023 Apr; 249():114135. PubMed ID: 36758443
[TBL] [Abstract][Full Text] [Related]
12. HBM4EU chromates study - Reflection and lessons learnt from designing and undertaking a collaborative European biomonitoring study on occupational exposure to hexavalent chromium.
Galea KS; Porras SP; Viegas S; Bocca B; Bousoumah R; Duca RC; Godderis L; Iavicoli I; Janasik B; Jones K; Knudsen LE; Leese E; Leso V; Louro H; Ndaw S; Ruggieri F; Sepai O; Scheepers PTJ; Silva MJ; Wasowicz W; Santonen T
Int J Hyg Environ Health; 2021 May; 234():113725. PubMed ID: 33714856
[TBL] [Abstract][Full Text] [Related]
13. Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment.
Apel P; Rousselle C; Lange R; Sissoko F; Kolossa-Gehring M; Ougier E
Int J Hyg Environ Health; 2020 Sep; 230():113622. PubMed ID: 33045523
[TBL] [Abstract][Full Text] [Related]
14. European interlaboratory comparison investigations (ICI) and external quality assurance schemes (EQUAS) for the analysis of bisphenol A, S and F in human urine: Results from the HBM4EU project.
Vaccher V; Lopez ME; Castaño A; Mol H; Haji-Abbas-Zarrabi K; Bury D; Koch HM; Dvorakova D; Hajslova J; Nübler S; Kaur Sakhi A; Thomsen C; Vorkamp K; Göen T; Antignac JP
Environ Res; 2022 Jul; 210():112933. PubMed ID: 35182598
[TBL] [Abstract][Full Text] [Related]
15. PFASs: What can we learn from the European Human Biomonitoring Initiative HBM4EU.
Uhl M; Schoeters G; Govarts E; Bil W; Fletcher T; Haug LS; Hoogenboom R; Gundacker C; Trier X; Fernandez MF; Calvo AC; López ME; Coertjens D; Santonen T; Murínová ĽP; Richterová D; Brouwere K; Hauzenberger I; Kolossa-Gehring M; Halldórsson ÞI
Int J Hyg Environ Health; 2023 May; 250():114168. PubMed ID: 37068413
[TBL] [Abstract][Full Text] [Related]
16. [Human Biomonitoring for Europe (HBM4EU)-first insights into the results of the initiative].
Weise P; Apel P; Kolossa-Gehring M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Sep; 65(9):936-939. PubMed ID: 35997778
[TBL] [Abstract][Full Text] [Related]
17. Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population.
Buekers J; David M; Koppen G; Bessems J; Scheringer M; Lebret E; Sarigiannis D; Kolossa-Gehring M; Berglund M; Schoeters G; Trier X
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30248963
[TBL] [Abstract][Full Text] [Related]
18. A step towards harmonising human biomonitoring study setup on European level: Materials provided and lessons learnt in HBM4EU.
Pack LK; Gilles L; Cops J; Tolonen H; van Kamp I; Esteban-López M; Pedraza-Díaz S; Lacasaña M; Alzaga BG; Lermen D; Bartel-Steinbach M; Katsonouri A; Fiddicke U; Castaño A; Kolossa-Gehring M
Int J Hyg Environ Health; 2023 Apr; 249():114118. PubMed ID: 36773579
[TBL] [Abstract][Full Text] [Related]
19. Interlaboratory comparison investigations (ICIs) and external quality assurance schemes (EQUASs) for flame retardant analysis in biological matrices: Results from the HBM4EU project.
Dvorakova D; Pulkrabova J; Gramblicka T; Polachova A; Buresova M; López ME; Castaño A; Nübler S; Haji-Abbas-Zarrabi K; Klausner N; Göen T; Mol H; Koch HM; Vaccher V; Antignac JP; Haug LS; Vorkamp K; Hajslova J
Environ Res; 2021 Nov; 202():111705. PubMed ID: 34297934
[TBL] [Abstract][Full Text] [Related]
20. Implementation of effect biomarkers in human biomonitoring studies: A systematic approach synergizing toxicological and epidemiological knowledge.
Rodríguez-Carrillo A; Mustieles V; Salamanca-Fernández E; Olivas-Martínez A; Suárez B; Bajard L; Baken K; Blaha L; Bonefeld-Jørgensen EC; Couderq S; D'Cruz SC; Fini JB; Govarts E; Gundacker C; Hernández AF; Lacasaña M; Laguzzi F; Linderman B; Long M; Louro H; Neophytou C; Oberemn A; Remy S; Rosenmai AK; Saber AT; Schoeters G; Silva MJ; Smagulova F; Uhl M; Vinggaard AM; Vogel U; Wielsøe M; Olea N; Fernández MF
Int J Hyg Environ Health; 2023 Apr; 249():114140. PubMed ID: 36841007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
